Development of human cytochrome P450-expressing cell lines: Application in mutagenicity testing of ochratoxin A

Cancer Research

Volumn 56, Issue 2, 1996, Pages 299-304

  De Groene, Els M ^a   Hassing, Ine G A M ^a   Blom, Maarten J ^a   Seinen, Willem ^a   Fink Gremmels, Johanna ^a   Horbach, G Jean ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; OCHRATOXIN;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL STRAIN 3T3; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE MUTATION; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING;

3T3 CELLS; ANIMALS; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; DNA MUTATIONAL ANALYSIS; GENETIC VECTORS; HUMANS; ISOENZYMES; LAC OPERON; MICE; MUTAGENICITY TESTS; MUTATION; MYCOTOXINS; OCHRATOXINS;

EID: 0030060757     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Guengerich, F. P. Characterization of human microsomal cytochrome P-450 enzymes. Annu. Rev. Pharmacol. Toxicol, 29: 241-264, 1989.
2. Guengerich, F. P. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol. Lett , 70: 133-138, 1994.
3. Guengerich, F. P., and Shimada, T Oxidation of toxic carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol., 4: 391-407, 1991
4. Wolf, C. R. Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals In: M Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky, and H. Bartsch (eds.), Mycotoxin, Endemic Nephropathy and Urinary Tract Tumours, pp 281-287. Lyon, France: IARC, 1991.
5. Senstag, C., Eugster, H-P , and Wurgler, F. E. High promutagen activating capacity of yeast microsomes containing human cytochrome P450 1A and human NADPH-cytochrome P450 reductase Carcinogenesis (Lond.), 15. 837-843, 1994
6. Josephy, P. D., DeBruin, L. S., Lord, H. L., Oak, J. N., Evans, D. H., Guo, Z., Dong, M-S., and Guengerich, F. P. Bioactivation of aromatic amines by recombinant human cytochrome P4501A2 expressed in Ames tester strain bacteria: a substitute for activation by mammalian tissue preparations. Cancer Res., 55: 799-802, 1995.
7. Gonzalez, F. J., Crespi, C. L., and Gelboin, H. V. cDNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment. Mutat. Res. 247: 113-127, 1991.
8. Langenbach, R., Smith, P B , and Crespi, C L. Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology. Mutat. Res., 277: 251-275, 1993.
9. Groene de, E M , Seinen, W., and Horbach, G. J. M J. A NIH/3T3 cell line stably expressing human CYP3A4 used in combination with a lacZ' shuttle vector to study mutagenicity Eur. J. Pharmacol., 293: 47-53, 1995.
10. Nouso, K , Thorgeirsson, S S., and Battula, N. Stable expression of human cytochrome P450IIE1 in mammalian cells: metabolic activation of nitrosodimethylamine and formation of adducts with cellular DNA Cancer Res., 52: 1796-1800, 1992.
11. Salompaa, P., Hakkala, J., Pasanen, M , Pelkonen, O., Vahakas, K., Battula, N., Nouso, K., and Rauno, H. Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells. Eur. J. Pharmacol., 248: 95-102, 1993.
12. Chu, F S Mycotoxins: food contamination, mechanism, carcinogenic potential and preventive measures. Mutat. Res., 259 291-306, 1991.
13. Boorman, G (ed) NTP Technical Report on the Toxicology and Carcinogenesis Studies of Ochratoxin A (NTP Report 358: NIH Publication 88-2813). Research Triangle Park, NC, National Toxicology Program, 1988.
14. Pepeljnjak, S., and Cvetnic, Z. The mycotoxicological chain and contamination of food by ochratoxin A in the nephropathic and non-nephropathic area in Yugoslavia. Mycopathologica, 90: 147-153, 1985
15. Fink-Gremmels, J , Blom, M J , Woutersen van Nijnanten, F M A., de Groene, E. M., and Horbach, G. J. M. J The influence of biotransformation in the epidemiology of ochratoxicosis. VIII International Symposium on Toxic Microorganisms, pp. 107-121 Fort Collins, CO. Alaken, Inc , 1994
16. Bendele, A. M , Neal, S B., Oberly, T. J., Thompson, C. Z., Bewsey, B. J , Hill, L. E., Rexroat, M. A., Carlton, W. W , and Probst, G. Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assays. Food Chem. Toxicol., 23: 911-918, 1985.
17. Wurgler, F. E., Friedrich, U., and Schlauer, J. Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102 Mutat Res., 261: 209-216, 1991.
18. Hennig, A., Fink-Gremmels, J , and Leistner, L Mutagenicity and effects of ochratoxin A on the frequency of sister chromatid exchange after metabolic activation. In: M. Castegnaro, R. Plestina, G. Dirheimer, I. N Chemozemsky, and H. Bartsch (eds.), Mycotoxin, Endemic Nephropathy and Urinary Tract Tumours, pp. 255-260. Lyon. France: IARC, 1991
19. Malaveille, C., Brun, G., and Bartsch, H. Structure-activity studies in E coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and cytotoxic thiol derivate as reactive metabolites Mutat. Res , 307: 141-147, 1994.
20. Strømer, F C., Støren, O , Hansen, C. E., Pedersen, J. I., and Assen, A. J Formation of (4R)- and (4S)-hydroxyochratoxin A and 10-hydroxyochratoxin A from ochratoxin A by rabbit liver microsomes. Appl Environ. Microbrol., 45: 1183-1187, 1983
21. Fink-Gremmels, J , Blom, M J., and Woutersen van Nijnanten, F. A. M. In vitro investigations on ochratoxin A metabolism. In. E. E. Creppy, M. Castegnaro, and G. Dirheimer (eds). Human Ochratoxicosis and Its Pathologies, Vol. 231, pp. 67-74. London: Collogue INSERM/John Libbey Eurotext Ltd., 1993.
22. Oster, T , Jayyosi, Z , Creppy, E. E., Souhili El Amri, H , and Batt, A. M Characterization of pig liver purified cytochrome P450 isoenzymes for ochratoxin A metabolism studies Toxicol. Lett., 57, 203-214, 1991.
23. Castegnaro, M., Bartsch, H., Béréziat, J-C., Arvela, P., Michelon, J., and Brousolle, L. Polymorphic ochratoxin A hydroxylation in rat strains phenotyped as poor and extensive metabolizers of debrisoquine. Xenobiotica, 19: 225-230, 1989.
24. Hietanen, E., Malaveille, C., Camus, A-M., Béréziat, J-C , Brun, G., Castegnaro M., Michelon, J., Idle, J. R., and Bartsch, H Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine. Drug Metab. Dispos., 14: 118-126, 1986.
25. Hietanen, E., Bartsch, H. Béréziat, J-C., Castegnaro, M., and Michelon, J. Characterization of the cytochrome P450 isozyme that metabolizes ochratoxin A, using metabolic inducers, inhibitors and antibodies. In: M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky, and H. Bartsch (eds.), Mycotoxin, Endemic Nephropathy and Urinary Tract Tumours, pp 297-304. Lyon. France. IARC, 1991.
26. Fink-Gremmels, J., Blom, M. J., and Woutersen van Nijnanten, F. M. A. Comparative aspects of ochratoxin A metabolism. In: K. A. Scudamore (ed.), Proceedings of the UK Workshop on Occurrence and Significance of Mycotoxins, pp. 124-130. Brunel, UK: Maff, Inc., 1993.
27. Jaiswal, A. K., Gonzalez, F. J., and Nebert, D. W. Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence Science (Washington DC), 228: 80-83, 1985
28. Jaiswal, A. K., Nebert, D. W., and Gonzalez, F. J Human P3-450: cDNA and complete amino acid sequence. Nucleic Acids Res., 14: 6773-6774, 1986.
29. Gonzalez, F. J., Skoda, R. D., Kimura, S., Umeno, M., Zanger, U. M., Nebert, D. W., Gelboin, H. V., Hardwick, J. P., and Meyer, U. A. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature (Lond), 331: 442-446, 1988
30. Umeno, M., McBride, O W., Yang, C S., Gelboin, H. V , and Gonzalez, F. J. Human ethanol-inducible P450IIE1: complete sequence, promoter characterization, chromosome mapping, and cDNA directed expression. Biochemistry, 27. 9006-9013, 1988.
31. Ged, C., Umbenhauer, D. R , Bellew, T M., Bork, R. W., Srivastava, P. K., Shinriki, N., Lloyd, R. S , and Guengerich, F. P. Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P450 (S)-mephenytoin-4′-hydroxylase. Biochemistry, 27: 6929-6940, 1988
32. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-990, 1989.
33. Mann, R., Mulligen, R C , and Baltimore, D Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell. 33: 153-159, 1983.
34. Graham, F. L , and Van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52: 456-467, 1973.
35. Gough, N. M. Rapid and quantitative preparation of cytoplasmic RNA from small number of cells. Anal. Biochem., 173: 93-95, 1988
36. Kennedy, S. W., Lorenzen, A , James, C A , and Collins, B. T Ethoxyresorufin-O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multiwell plate reader. Anal. Biochem., 211: 102-112, 1993.
37. PA (P4501A2): the phenacetin o-deethylase is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad Sci. USA, 86: 7696-7700, 1989
38. Knodell, R. G., Hall, S D., Wilkinson, G. R., and Guengerich, F. P. Hepatic metabolism of tolbutamide characterization of the form of cytochrome P450 involved in methylhydroxylase and relationship to in vivo disposition. J. Pharmacol Exp. Ther., 241: 1112-1119, 1987
39. Kronbach, T., Mathys, D , Gut, J., Catin, T., and Meyer, U A. High performance liquid chromatographic assays for bufuralol-1′-hydroxylase, debrisoquine 4-hydroxylase and dextromethorphan O-demethylase in microsomes and purified cytochrome P450 isozymes of human liver. Anal. Biochem., 162: 24-32, 1987.
40. Wrighton, S. A., Thomas, P. E , Ryan, D E., and Levin, W. Purification and characterization of ethanol-inducible human hepatic cytochrome P450KLj Arch Biochem. Biophys., 258. 292-297, 1987
41. Waxman, D. J , Ko, A., and Walsh, C. Regioselectivity of androgen hydroxylations catalysed by cytochrome P450 isozymes purified from phenobarbital-induced rat liver. J. Biol Chem., 285: 11937-11947, 1983.
42. Wortelboer, H. M., de Kruif, C. A., van Iersel, A A. J., Falke, H. E., Noordhoek, J., and Blaauboer, B. J. The isozyme pattern of cytochrome P450 in rat hepatocytes in primary culture, comparing different enzyme activities in microsomal incubations and in intact monolayers. Biochem. Pharmacol., 40: 2525-2534, 1990.
43. Hirt, B. Selective extraction of polyoma DNA from infected mouse cell cultures J. Mol Biol , 26: 365-369, 1967.
44. Crespi, C. L , Langenbach, R., and Penman, B. W. Human cell lines derived from AHH-1 TKz human lymphoblasts, genetically engineered for expression of cytochromes P450. Toxicology, 82: 89-104, 1993.
45. Doehmer, J. V79 Chinese hamster cells genetically engineered for cytochrome P450 and their use in mutagenicity and metabolism studies Toxicology, 82: 105-118, 1993.